Android app Apple app link

PTC Therapeutics, Inc. (PTCT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$41.85

south_east
-$2.2 (-4.99%)
Day's range
$41.67
Day's range
$44.69

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/07/2025 RBC Capital Brian Abrahams $58.00 $44.61   30.02%
11/27/2024 Robert W. Baird Joel Beatty $52.00 $45.09   15.34%
10/11/2024 Morgan Stanley Jeffrey Hung $45.00 $38.48   16.94%
08/26/2024 UBS Colin Bristow $47.00 $34.99   34.32%
07/12/2024 Morgan Stanley Jeffrey Hung $32.00 $33.20   -3.61%
05/20/2024 Goldman Sachs Paul Choi $32.00 $40.12   -20.24%
05/20/2024 Jefferies Kelly Shi $46.00 $39.81   15.55%
04/26/2024 Morgan Stanley Jeffrey Hung $30.00 $28.57   5.01%
08/30/2021 UBS Colin Bristow $45.00 $43.65   3.09%

PTC Therapeutics, Inc. FAQ's

What analysts cover PTC Therapeutics, Inc.?

PTC Therapeutics, Inc. has been rated by research analysts at RBC Capital, Robert W. Baird, Morgan Stanley, UBS, Goldman Sachs, Jefferies in the past 90 days.

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.